Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Mobile Low-dose Computed Tomography (LDCT) Screening.
- Who it may be relevant to
- Registry conditions: Lung Neoplasms, Lung Cancer. Basic parameters: 40 years — 54 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Lung B.A.S.E.S 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Assessing Incidence and Stage of Lung Cancer Diagnosis in Subjects Ages 40-54 With a 30 Pack Year History or More Within North and South Carolina
Overview
Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.
Detailed description
The primary objective of this study is to evaluate the lung cancer diagnosis rate in individuals 40-54 years of age at their first screening (T0) with mobile low-dose CT. Secondary objectives include evaluating the lung cancer diagnosis rate in individuals 40-54 years of age at subsequent screening visits (T1 and T2); evaluating the positive screening rate at T0, T1, and T2; evaluating the impact of baseline demographic (including insurance status), socioeconomic, and healthcare-related factors on lung cancer rates and positive screening rates; and summarizing the incidence rate of all types of cancer found with low-dose lung CT during lung cancer screening. Enrollment will continue until 174 subjects are identified in the evaluable population with a total of 1160 subjects anticipated to be enrolled and screened.
Interventions
- Other Mobile Low-dose Computed Tomography (LDCT) Screening
Low Dose CT Scan of the Chest
Primary outcome measures
- Lung cancer diagnosis rate in individuals 40-54 years of age at their first screening (T0) with mobile low-dose CT. [Time frame: 1 day]
Secondary outcome measures (4)
- Lung cancer diagnosis rate in individuals 40-54 years of age at subsequent screening visits (T1 and T2) [Time frame: up to 24 months]
- Positive screening rate at T0, T1, and T2 [Time frame: up to 24 months]
- Impact of baseline demographic (including insurance status), socioeconomic, and healthcare-related factors on lung cancer rates and positive screening rates [Time frame: up to 24 months]
- Incidence rate of all types of cancer found with low-dose lung CT during lung cancer screening [Time frame: up to 24 months]
Eligibility criteria
Inclusion criteria
- Subject must meet all the following applicable inclusion criteria to participate in this study:
- Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
- Age 40-54 years at the time of consent.
- A positive smoking history of greater/equal to 30 pack years and they are either currently smoking or have quit within the last 15 years.
- Ability to read and understand the English and/or Spanish language.
- Ability to understand and comply with study procedures for the entire length of the study.
Exclusion criteria
- Subjects meeting any of the criteria below may not participate in the study:
- Known diagnosis of lung cancer in the past 5 years.
- Any known contraindication to having a low-dose CT Scan.
- Known pregnancy.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Screening
Study locations
United States · 1 center
- Levine Cancer Institute — Charlotte
Identifiers
NCT: NCT04577599 · IRB00081444 · 00045190 · LCI-LUN-NOS-MoCT-002